Lanreotide vs Tesamorelin
Overview
Lanreotide is primarily a hormonal peptide, while Tesamorelin is used for performance & growth.
This page compares Lanreotide and Tesamorelin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Lanreotide | Tesamorelin | |
|---|---|---|
| Category | Hormonal | Performance & Growth |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 60-120 mg | 2 mg |
| Frequency | every 4 weeks | daily |
| Reported benefits | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones | Visceral fat reduction, improved body composition, GH release |
| Reported side effects | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases | Joint pain, peripheral edema |
Key differences
Primary use. Lanreotide is categorised under Hormonal, while Tesamorelin falls under Performance & Growth. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Lanreotide: FDA-approved. Tesamorelin: FDA-approved.
Dosing. Lanreotide is typically dosed at 60-120 mg (every 4 weeks). Tesamorelin is typically dosed at 2 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking Lanreotide and Tesamorelin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Lanreotide and Tesamorelin?
- Lanreotide is primarily a hormonal peptide, while Tesamorelin is used for performance & growth. Lanreotide is FDA-approved for one or more indications, whereas Tesamorelin is FDA-approved for one or more indications.
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- What is Tesamorelin used for?
- GHRH for visceral fat.
- Can you take Lanreotide and Tesamorelin together?
- Some users combine peptides within a single protocol, but stacking Lanreotide and Tesamorelin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Lanreotide or Tesamorelin FDA-approved?
- Lanreotide is FDA-approved for one or more indications. Tesamorelin is FDA-approved for one or more indications.
Read the full articles
- Lanreotide — full monograph: mechanism, research, dosing & references
- Tesamorelin — full monograph: mechanism, research, dosing & references